PROBLEM: The pathogenesis of uterine leiomyomata is still unclear. Recently
it has been suggested that mac25 prays a tumor-suppressive role in various
tumors. The aims of this study were to evaluate a possible involvement of
mac25 in the growth of leiomyoma and in the mechanism of a gonadotropin-rel
easing hormone agonist (GnRHa) inducing shrinkage of leiomyoma.
METHODS OF STUDY: Mac25 mRNA transcript was measured by Northern blot in to
tal RNA extracted from the paired specimens of leiomyoma and adjacent myome
trium from untreated patients (n = 25) and from leiomyoma specimens from Gn
RHa-pretreated patients (n = 10).
RESULTS: Mac25 mRNA expression was significantly lower in large leiomyoma (
more than 150 cm(3) in volume) than in adjacent myometrium and small leiomy
oma (less than 120 cm(3) in volume) from untreated patients. There was no d
ifference in this expression between the proliferative and secretory phases
of the menstrual cycle. Leiomyoma from GnRHa-pretreated patients had mac25
gene expression levels similar to myometrium and small leiomyoma from untr
eated patients.
CONCLUSIONS: Mac25 may be involved in the growth of uterine leiomyoma and t
he action of GnRHa may, in part, be mediated by mac25.